NAD-Driven Sirtuin Activation by Cordyceps sinensis Extract: Exploring the Adaptogenic Potential to Promote Skin Longevity.
Ritamaria Di LorenzoDanila FalangaLucia RicciAntonio ColantuonoGiovanni GrecoMaura AngelilloFiorella NugnesTeresa Di SerioDorothea CostaAnnalisa TitoSonia LaneriPublished in: International journal of molecular sciences (2024)
In recent years, there has been increasing interest in utilizing Traditional Chinese Medicine principles and natural bioactive compounds to combat age-related ailments and enhance longevity. A Cordyceps sinensis mycelium hydroethanolic extract (CsEx), which was standardized in cordycepin and adenosine using UHPLC-DAD, was investigated for its adaptogenic properties using in vitro assays and a double-blind, placebo-controlled clinical trial involving 40 subjects. The CsEx demonstrated activity at a concentration of 0.0006%, significantly increasing sirtuin expression (SirT1: +33%, SirT3: +10%, SirT6: +72%, vs. CTR, p < 0.05) and NAD+ synthesis in HaCat cells (+20% vs. CTR, p < 0.001). Moreover, the CsEx boosted ATP production by 68% in skin cells, correlating with higher skin energy values (+52.0% at D 28 , p < 0.01) in the clinical trial. Additionally, CsEx notably reduced cytosolic reactive oxygen species (ROS) by 30% in HaCaT cells ( p < 0.05) and enhanced collagen production both in vitro (+69% vs. CTR, p < 0.01) and in vivo (+10% vs. D0, p < 0.01), confirmed by ultrasound examination. Furthermore, CsEx's stimulation of fibroblasts, coupled with its antioxidant and energizing properties, led to a significant reduction in wrinkles by 28.0% (D28, p < 0.001). This study underscores Cordyceps sinensis hydroethanolic extract's potential in regulating skin cell energy metabolism and positively influencing the mechanisms associated with skin longevity control.
Keyphrases
- oxidative stress
- induced apoptosis
- clinical trial
- wound healing
- soft tissue
- cell cycle arrest
- reactive oxygen species
- double blind
- anti inflammatory
- ischemia reperfusion injury
- study protocol
- magnetic resonance imaging
- poor prognosis
- randomized controlled trial
- endoplasmic reticulum stress
- single cell
- placebo controlled
- computed tomography
- stem cells
- squamous cell carcinoma
- high resolution
- bone marrow
- risk assessment
- mass spectrometry
- open label
- cell proliferation
- single molecule
- cell therapy
- binding protein
- phase ii study
- mesenchymal stem cells
- tandem mass spectrometry
- atomic force microscopy